Cargando…

Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab

Detalles Bibliográficos
Autores principales: Siegel, Jacob D., Bhatia, Aarti, Ko, Christine J., Christensen, Sean R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577130/
https://www.ncbi.nlm.nih.gov/pubmed/34778502
http://dx.doi.org/10.1016/j.jdcr.2021.10.009
_version_ 1784596016178135040
author Siegel, Jacob D.
Bhatia, Aarti
Ko, Christine J.
Christensen, Sean R.
author_facet Siegel, Jacob D.
Bhatia, Aarti
Ko, Christine J.
Christensen, Sean R.
author_sort Siegel, Jacob D.
collection PubMed
description
format Online
Article
Text
id pubmed-8577130
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-85771302021-11-12 Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab Siegel, Jacob D. Bhatia, Aarti Ko, Christine J. Christensen, Sean R. JAAD Case Rep Case Report Elsevier 2021-10-20 /pmc/articles/PMC8577130/ /pubmed/34778502 http://dx.doi.org/10.1016/j.jdcr.2021.10.009 Text en © 2021 Published by Elsevier on behalf of the American Academy of Dermatology, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Siegel, Jacob D.
Bhatia, Aarti
Ko, Christine J.
Christensen, Sean R.
Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab
title Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab
title_full Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab
title_fullStr Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab
title_full_unstemmed Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab
title_short Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab
title_sort concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577130/
https://www.ncbi.nlm.nih.gov/pubmed/34778502
http://dx.doi.org/10.1016/j.jdcr.2021.10.009
work_keys_str_mv AT siegeljacobd concurrentdevelopmentofhighstagecutaneoussquamouscellcarcinomaduringcompleteresponseofmetastaticcutaneoussquamouscellcarcinomatoprogrammedcelldeathprotein1blockadewithcemiplimab
AT bhatiaaarti concurrentdevelopmentofhighstagecutaneoussquamouscellcarcinomaduringcompleteresponseofmetastaticcutaneoussquamouscellcarcinomatoprogrammedcelldeathprotein1blockadewithcemiplimab
AT kochristinej concurrentdevelopmentofhighstagecutaneoussquamouscellcarcinomaduringcompleteresponseofmetastaticcutaneoussquamouscellcarcinomatoprogrammedcelldeathprotein1blockadewithcemiplimab
AT christensenseanr concurrentdevelopmentofhighstagecutaneoussquamouscellcarcinomaduringcompleteresponseofmetastaticcutaneoussquamouscellcarcinomatoprogrammedcelldeathprotein1blockadewithcemiplimab